About this trial
The purpose of this study is to measure intraoperative embolic burden during prophylactic intramedullary nailing of impending femur fractures in patients treated with versus without venting, to find the association between embolic burden and intraoperative physiologic changes, measured using standard anesthesia monitors and charted data, to measure Immediate and short-term cardiopulmonary outcomes assessed during hospitalization and to assess procedure-related complications associated with venting
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of an impending femur fracture requiring prophylactic intramedullary fixation
Long-term bisphosphonate use, or
Oncologic disease without radiographic evidence of cortical disruption
Ability to provide informed consent
Disqualifiers
Inability to obtain adequate intraoperative transthoracic echocardiography (TTE) imaging windows for visualization of right-sided cardiac structures
Inability to tolerate or safely undergo TTE monitoring per anesthesia determination
Any intraoperative technical limitation preventing reliable echocardiographic data acquisition
Trial design
Parallel
Treatments tested in this trial
Femoral venting+ intramedullary nailing
Procedure/SurgeryParticipants will undergo femoral venting prior to prophylactic intramedullary fixation .
Standard intramedullary nailing
Procedure/SurgeryParticipants will undergo prophylactic intramedullary fixation
Treatment groups
Trial outcomes
Primary outcomes
Change in Embolic burden as assessed by intraoperative transthoracic echocardiography (TTE)
Embolic burden is defined as the presence, frequency, and severity (graded semi-quantitatively) of echogenic embolic events within the right atrium, right ventricle, and pulmonary artery outflow tract.
Secondary outcomes
Change in Embolic Burden as assessed by change in Heart rate
Change in Embolic Burden as assessed by change in Mean arterial pressure
Change in Embolic Burden as assessed by change in oxygen saturation
Change in Embolic Burden as assessed by change in end-tidal carbon dioxide
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: